Marlana Ray, MD
NPI 1285164756 · Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician · North Kansas City, MO
Enrolled with Medicare as Practitioner - Obstetrics/Gynecology · source: CMS PECOS Public Provider Enrollment (2026.04.01)
Marlana Ray, MD is a Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician provider in North Kansas City, MO (NPI 1285164756).
Provider details
- NPI number
- 1285164756
- Entity type
- Individual
- Primary specialty
- Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) PhysicianAllopathic & Osteopathic Physicians
- Credential
- MD
- Sex
- Female
- Sole proprietor
- No
- License
- RS2019-0631 (NM)
Specialties & taxonomies
- Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) PhysicianPrimary207VF0040XLicense 2024022799 (MO)
Allopathic & Osteopathic Physicians
Student, Health Care
- Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician207VF0040XLicense 35.142117 (OH)
Allopathic & Osteopathic Physicians
Profile Score
A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.
- Registry tenure25% of score
9 yrs in NPPES registry
- Profile completeness25% of score
100% of core fields populated
- Practice footprint15% of score
1 documented practice location
- Medicare service volume (vs. specialty peers)25% of score
92 Medicare services, 2024 (ranked within specialty)
- Open Payments transparency10% of score
Has Open Payments disclosures (2024)
Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our .
What this provider does (Medicare)
Based on Medicare fee-for-service claims, 2024; not all care is captured.
| Service (HCPCS) | Medicare services | Typical Medicare-allowed (2024) |
|---|---|---|
| Insertion of Temporary Bladder Tube51701 | 33 | $41 |
| New Patient Office Or Other Outpatient Visit With Moderate Level of Medical Decision Making, If Using Time, 45 Minutes Or More99204 | 23 | $161 |
| Automated Urinalysis Test81003 | 18 | $2 |
| Established Patient Office Or Other Outpatient Visit With Moderate Level of Decision Making, If Using Time, 30 Minutes Or More99214 | 18 | $123 |
Typical Medicare-allowed amounts for these services range $2–$161 (2024). The Medicare-allowed amount is what Medicare recognizes for a service under fee-for-service — a reference figure for 2024, not a price quote and not what you would be billed. Medicare Part B covers roughly an eighth of all NPIs (65+ skew); services with fewer than 11 beneficiaries are suppressed by CMS. Source: CMS Medicare Physician & Other Practitioners, by Provider & Service.
What this provider prescribes (Medicare Part D)
Top drugs by Medicare Part D claim volume, 2024 · 7 distinct drugs on file.
| Drug | Part D claims (2024) | Beneficiaries |
|---|---|---|
| Estradiol | 35 | 29 |
| Solifenacin Succinate | 25 | 11 |
| Mirabegronbrand: Myrbetriq | 24 | 13 |
| Vibegronbrand: Gemtesa | 18 | — |
| Trimethoprim | 14 | — |
| Nitrofurantoin Monohyd/M-Crystbrand: Nitrofurantoin Mono-Macro | 12 | — |
| Clobetasol Propionate | 12 | — |
These counts cover prescriptions paid through Medicare Part D in 2024 — they include cash-pay, commercial-insurance, Medicaid, or Part B–administered drugs, and badly undercount high cash-pay categories (e.g. GLP-1 weight-loss, testosterone, and ED medications). Any drug with 10 or fewer claims is omitted by CMS, and beneficiary counts under 11 are suppressed — so a missing drug means , never zero. This is a factual claims summary, not an endorsement, not medical advice, and not a consumer report. Source: CMS Medicare Part D Prescribers — by Provider and Drug.
Transparency — industry payments
Based on CMS Open Payments, 2024; not all care is captured.
$262 across 3 records (Open Payments 2024)
Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.
Practice location
Mailing address
Registry dates
- Enumerated
- 2017-06-15
- Last updated
- 2025-09-12
- Certified
- 2024-10-29
Frequently asked questions
- What is Marlana Ray's NPI number?
- Marlana Ray's National Provider Identifier (NPI) is 1285164756, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.
- What is Marlana Ray's specialty?
- Marlana Ray is listed in the NPPES registry with a primary specialty of Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician (Allopathic & Osteopathic Physicians).
- Where is Marlana Ray located?
- Marlana Ray's practice location on file with NPPES is 2750 Clay Edwards Dr Ste 312, North Kansas City, MO 64116-3256.
- What is Marlana Ray's phone number?
- The practice phone number listed in the NPPES registry for Marlana Ray is (816) 691-1185.
- Does Marlana Ray accept Medicare?
- Marlana Ray is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.
- Is Marlana Ray's NPI active?
- Yes — Marlana Ray's NPI (1285164756) is active in the NPPES registry as of the last update on 2025-09-12.
Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.